Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases
Developmental Medicine & Child Neurology · 2025-01 · 67 (1) · 126-131
DOI: 10.1111/dmcn.15985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 05.06.2024. Verfasst von Pamela Bowman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Royal Devon University NHS Foundation Trust, Exeter, UK. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Rare Diseases, Whole Genome Sequencing. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
First‐line genetic investigations for rare neurological and developmental conditions have limitations in their ability to detect and characterize copy number variants (CNVs). Whole genome sequencing (WGS) offers potential advantages over other methods of CNV analysis. We aimed to demonstrate the utility of CNV detection using WGS through description of three clinical cases. WGS analysis was undertaken in three patients presenting to a national rare disease service, in whom a genetic aetiology remained uncertain after gene panel testing or microarray based comparative genomic hybridization (array CGH). In all three cases, WGS identified CNVs and confirmed zygosity and pathogenicity, resulting in genetic diagnoses of PRKN ‐related Parkinson disease, TAOK1 ‐related neurodevelopmental disorder, and AP1G1 ‐related Usmani‐Riazuddin syndrome. This case series demonstrates the value of WGS analysis in identifying or better characterizing CNVs that were missed or deemed of uncertain significance using conventional methods of testing. Importantly, our approach facilitated accurate genetic diagnosis and counselling for the families involved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Royal Devon University NHS Foundation Trust, Exeter, UK.
- University of Exeter, Exeter, UK.
- Somerset NHS Foundation Trust, Taunton, Somerset, UK.
- South West Genomic Laboratory Hub, North Bristol NHS Trust, Bristol, UK.
- Department of Neurology, University Hospitals Plymouth NHS Trust, Plymouth, UK.
- Department of Clinical Genetics, UHBW NHS Trust, Bristol, UK.
ORCID-Profile: Pamela Bowman, Anthony R Dallosso
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Bowman, P., Grimes, H., Dallosso, A. R., Berry, I., Mullin, S., Rankin, J., & Low, K. J. (2025). Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases. Developmental Medicine & Child Neurology, 67(1), 126-131. https://doi.org/10.1111/dmcn.15985
Vancouver
Bowman P, Grimes H, Dallosso AR, Berry I, Mullin S, Rankin J, et al. Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases. Developmental Medicine & Child Neurology. 2025;67(1):126-131. doi:10.1111/dmcn.15985
BibTeX
@article{Bowman2025,
author = {Bowman, Pamela and Grimes, Hannah and Dallosso, Anthony R and Berry, Ian and Mullin, Stephen and Rankin, Julia and Low, Karen J},
title = {Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases},
journal = {Developmental Medicine & Child Neurology},
year = {2025},
volume = {67},
number = {1},
pages = {126--131},
doi = {10.1111/dmcn.15985}
}
EUVIMED